Stay updated with breaking news from Human Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
David Spencer, MD, director of the Comprehensive Epilepsy Center and professor of neurology at Oregon Health and Science University, talks about how an emerging epilepsy treatment could transform the current level of care for patients with the condition.
Multiple doses achieved sustained target exposure of ~80%+ mutant PI3Kα inhibition No Grade 3 hyperglycemia, rash or diarrhea observed at target exposures Favorable initial safety profile at... | April 18, 2023
The annual meeting of the American Academy of Neurology (AAN) will take place April 22-27 in Boston, presenting in a hybrid format a schedule packed with continuing medical education sessions, poster presentations, and cutting-edge science.
Iran starts human trial of its first homegrown coronavirus vaccine developed and manufactured on the basis of the messenger ribonucleic acid (mRNA) technology.
Wonder no more why some quarters are insistent on getting more people vaccinated despite the Wuhan coronavirus (COVID-19) pandemic having fizzled out. They want to perpetuate the COVID narrative [...]